The Scientist

» Alzheimer's Disease and disease/medicine

Most Recent

image: Breaching the Blood-Brain Barrier

Breaching the Blood-Brain Barrier

By | November 11, 2015

Researchers deliver cancer-fighting drugs to a patient’s brain via the bloodstream, penetrating the blood-brain barrier for the first time.

0 Comments

image: Life Scientists Honored

Life Scientists Honored

By | November 9, 2015

Breakthrough Prizes of $3 million each go to five researchers in the life sciences, recognizing their pioneering work in optogenetics, disease-associated mutation analyses, and ancient DNA sequencing.

1 Comment

Some antibodies designed to eliminate the plaques prominent in Alzheimer’s disease can aggravate neuronal hyperactivity in mice.

1 Comment

image: Week in Review: November 2–6

Week in Review: November 2–6

By | November 6, 2015

How Ebola hides from immune cells; gut microbes’ role in immunotherapy response; new mechanisms of hearing loss; butterflies use milkweed toxins to ward off predators

0 Comments

image: A Weighty Anomaly

A Weighty Anomaly

By | November 1, 2015

Why do some obese people actually experience health benefits?

3 Comments

image: Battling the Bulge

Battling the Bulge

By | November 1, 2015

Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

0 Comments

image: Contributors

Contributors

By | November 1, 2015

Meet some of the people featured in the November 2015 issue of The Scientist.

0 Comments

image: Weight's the Matter?

Weight's the Matter?

By | November 1, 2015

The causes and consequences of obesity are more complicated than we thought.  

0 Comments

image: Toward Protecting Participants’ Privacy

Toward Protecting Participants’ Privacy

By | October 29, 2015

Genomic data shared via the Beacon Project are vulnerable to privacy breaches, scientists show.

1 Comment

image: FDA OKs Herpesvirus to Treat Cancer

FDA OKs Herpesvirus to Treat Cancer

By | October 28, 2015

The US Food and Drug Administration’s approval of an engineered herpesvirus for the treatment of melanoma marks the first oncolytic virus to enter the market.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Cannibalism: Not That Weird
    Reading Frames Cannibalism: Not That Weird

    Eating members of your own species might turn the stomach of the average human, but some animal species make a habit of dining on their own.

  3. Henrietta Lacks’s Family Seeks Compensation
  4. Can Plants Learn to Associate Stimuli with Reward?
Business Birmingham